Related Experiment Video
Updated: Jun 19, 2026
08:25
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
THE HEART MUSCLE IN PNEUMONIA
1Laboratory of Comparative Physiology and the Department of Medicine of the Harvard Medical School, Boston.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Heart muscle function is preserved in pneumonia, but direct exposure to pneumonic blood impairs cardiac efficiency. The heart can adapt to gradual exposure to toxins associated with pneumonia.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Pathophysiology
Background:
- Pneumonia can affect systemic functions beyond the lungs.
- The impact of pneumonia on cardiac muscle contractility requires further elucidation.
Purpose of the Study:
- To investigate the functional status of heart muscle during pneumonia.
- To determine the effects of pneumonic blood on normal cardiac muscle.
- To assess the adaptive capacity of heart muscle to pneumonic toxins.
Main Methods:
- Assessing ventricular function in the context of pneumonia.
- Introducing pneumonic blood to normal cardiac tissue to observe functional changes.
- Evaluating cardiac muscle response to gradual exposure to pneumonia-related toxins.
Main Results:
- Heart muscle in pneumonia demonstrates normal function when supplied with normal blood.
- Sudden exposure of normal heart muscle to pneumonic blood significantly reduces cardiac efficiency, contractility duration, and area.
- Gradual exposure to pneumonia-associated toxins allows the heart muscle to adapt and partially adjust its function.
Conclusions:
- Cardiac muscle retains functional integrity during pneumonia if adequately supplied.
- Pneumonic blood poses an acute risk to cardiac function, impairing contractility.
- The heart exhibits a degree of plasticity, adapting to sustained exposure to pneumonia-induced cardiac stressors.
More Related Videos
Related Concept Videos
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: